Dabur India Posts 11.7% Q2 PAT Growth; Declares ₹3.50 Interim Dividend
Dabur India Ltd · Press Release · 04 Nov 2026, 10:16 pm
Dabur India Posts 11.7% Q2 PAT Growth; Declares ₹3.50 Interim Dividend For Q2 ended 30th Sep'26, Dabur India reported consolidated revenue growth of 11.6% YoY to ₹3,563 crore, with PAT rising 11.7% YoY to ₹505 crore. Domestic FMCG revenue grew 10.7% with 5.5% underlying volume growth, while international business expanded 20% in INR terms. Segment-wise, F&B rose 17.4%, HPC gained 10.9%, and Healthcare grew 6.9%. H1 revenue and PAT stood at ₹7,327 crore and ₹1,096 crore, up 11.1% and 13.4% YoY, respectively. The board approved an interim dividend of ₹3.50 per share (350%), totaling ₹620.88 crore.
Original exchange filing (PDF)
More announcements from Dabur India Ltd
- Re-affirmation of Credit Rating by CRISIL Ratings Limited · 17 Nov 2026
- Change in Senior Management Personnel of the Company · 14 Nov 2026
- Closure of Dabur International Limited, United Kingdom Branch, a branch of the wholly owned subsidiary of the Company. · 14 Nov 2026
- Submission of information under Regulation 30(5) of the SEBI (LODR) Regulations, 2015 · 13 Nov 2026
- Dissolution of Dabur Pars LLC a subsidiary of Dabur International Limited, a wholly owned subsidiary of the Company. · 11 Nov 2026
- Closure of Atlanta Body and Health Products (Pty) Ltd., a wholly owned subsidiary of Dermoviva Skin Essentials Inc. a step down subsidiary of the Company. · 10 Nov 2026
- Transcript of Analyst/ Institutional Investor Meet held on November 05, 2026 · 10 Nov 2026
- Receipt of administrative warning letter from SEBI · 06 Nov 2026
